Azzota Corp CFI-400945
Manufacturer: Azzota Corp C1105
CFI-400945 is an orally available PLK4 (polo-like kinase 4) inhibitor with potential antineoplastic activity. CFI-400945 selectively inhibits PLK4, which results in the disruption of mitosis and the induction of apoptosis. Please request if need more quantities
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok